JP2014524450A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014524450A5 JP2014524450A5 JP2014526385A JP2014526385A JP2014524450A5 JP 2014524450 A5 JP2014524450 A5 JP 2014524450A5 JP 2014526385 A JP2014526385 A JP 2014526385A JP 2014526385 A JP2014526385 A JP 2014526385A JP 2014524450 A5 JP2014524450 A5 JP 2014524450A5
- Authority
- JP
- Japan
- Prior art keywords
- pacap
- given
- concentration
- peptide
- molecular adjuvant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 239000002671 adjuvant Substances 0.000 claims 6
- 229960005486 vaccine Drugs 0.000 claims 6
- 239000000427 antigen Substances 0.000 claims 5
- 102000036639 antigens Human genes 0.000 claims 5
- 108091007433 antigens Proteins 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 230000003213 activating effect Effects 0.000 claims 3
- 108060000200 adenylate cyclase Proteins 0.000 claims 3
- 102000030621 adenylate cyclase Human genes 0.000 claims 3
- 238000007654 immersion Methods 0.000 claims 3
- 239000012678 infectious agent Substances 0.000 claims 3
- 238000002347 injection Methods 0.000 claims 3
- 239000007924 injection Substances 0.000 claims 3
- 230000001817 pituitary effect Effects 0.000 claims 3
- 108020004511 Recombinant DNA Proteins 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- 230000006806 disease prevention Effects 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 235000014105 formulated food Nutrition 0.000 claims 2
- 238000002955 isolation Methods 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 238000003786 synthesis reaction Methods 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 241000251468 Actinopterygii Species 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 244000078703 ectoparasite Species 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU2011000167A CU24075B1 (es) | 2011-08-26 | 2011-08-26 | Composición vacunal que comprende el péptido activador de la adenilato ciclasa de pituitaria como adyuvante molecular. |
| CU2011-0167 | 2011-08-26 | ||
| PCT/CU2012/000004 WO2013029570A1 (es) | 2011-08-26 | 2012-08-24 | Uso del pacap como adyuvante molecular para vacunas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014524450A JP2014524450A (ja) | 2014-09-22 |
| JP2014524450A5 true JP2014524450A5 (enExample) | 2015-04-02 |
| JP6077541B2 JP6077541B2 (ja) | 2017-02-08 |
Family
ID=47046313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014526385A Active JP6077541B2 (ja) | 2011-08-26 | 2012-08-24 | ワクチンのための分子アジュバントとしてのｐａｃａｐの使用 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9549977B2 (enExample) |
| EP (1) | EP2749291B1 (enExample) |
| JP (1) | JP6077541B2 (enExample) |
| KR (1) | KR101857705B1 (enExample) |
| CN (1) | CN103874510A (enExample) |
| AU (1) | AU2012303887B2 (enExample) |
| BR (1) | BR112014004620B1 (enExample) |
| CA (1) | CA2844898C (enExample) |
| CL (1) | CL2014000386A1 (enExample) |
| CU (1) | CU24075B1 (enExample) |
| ES (1) | ES2648337T3 (enExample) |
| MX (1) | MX351725B (enExample) |
| MY (1) | MY191697A (enExample) |
| NO (1) | NO2749291T3 (enExample) |
| PH (1) | PH12014500397B1 (enExample) |
| PT (1) | PT2749291T (enExample) |
| RU (1) | RU2580294C2 (enExample) |
| SG (1) | SG11201400215SA (enExample) |
| WO (1) | WO2013029570A1 (enExample) |
| ZA (1) | ZA201401271B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190060057A (ko) | 2017-11-24 | 2019-06-03 | 유병희 | 웰빙 무드등 |
| EP3970796B1 (en) * | 2019-05-14 | 2025-08-20 | Senju Pharmaceutical Co., Ltd. | Composition for preventing or treating neurotrophic keratitis which contains stabilized pacap peptide |
| CN117617183B (zh) * | 2023-11-29 | 2025-09-05 | 中国医学科学院医药生物技术研究所 | 突变体斑马鱼在制备凝血功能障碍疾病的动物模型中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE65568B1 (en) * | 1990-10-22 | 1995-11-01 | Unilever Plc | Vaccine compositions for fish |
| PE20010612A1 (es) * | 1999-09-28 | 2001-07-12 | Bayer Corp | Agonistas del receptor 3 (r3) del peptido activador de la adenilato ciclasa de la pituitaria y su uso farmacologico |
| GB0427267D0 (en) * | 2004-12-13 | 2005-01-12 | Maria Teresa De Magistris | Peptide adjuvants |
| CU23557A1 (es) | 2005-11-22 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Neuropéptidos para el cultivo de organismos acuáticos |
| CN102883739B (zh) * | 2009-11-02 | 2015-11-25 | 图兰恩教育基金管理人 | 垂体腺苷酸环化酶激活多肽（pacap）的类似物和它们的应用方法 |
| CN103255089B (zh) * | 2013-05-03 | 2015-08-05 | 中国水产科学研究院黄海水产研究所 | 一株强毒迟缓爱德华氏菌疫苗株及其应用 |
-
2011
- 2011-08-26 CU CU2011000167A patent/CU24075B1/es active IP Right Grant
-
2012
- 2012-08-24 JP JP2014526385A patent/JP6077541B2/ja active Active
- 2012-08-24 PH PH1/2014/500397A patent/PH12014500397B1/en unknown
- 2012-08-24 NO NO12775123A patent/NO2749291T3/no unknown
- 2012-08-24 US US14/238,377 patent/US9549977B2/en active Active
- 2012-08-24 CA CA2844898A patent/CA2844898C/en active Active
- 2012-08-24 CN CN201280041829.5A patent/CN103874510A/zh active Pending
- 2012-08-24 BR BR112014004620-4A patent/BR112014004620B1/pt active IP Right Grant
- 2012-08-24 ES ES12775123.8T patent/ES2648337T3/es active Active
- 2012-08-24 AU AU2012303887A patent/AU2012303887B2/en not_active Ceased
- 2012-08-24 MX MX2014002214A patent/MX351725B/es active IP Right Grant
- 2012-08-24 EP EP12775123.8A patent/EP2749291B1/en active Active
- 2012-08-24 SG SG11201400215SA patent/SG11201400215SA/en unknown
- 2012-08-24 KR KR1020147006186A patent/KR101857705B1/ko active Active
- 2012-08-24 WO PCT/CU2012/000004 patent/WO2013029570A1/es not_active Ceased
- 2012-08-24 MY MYPI2014700419A patent/MY191697A/en unknown
- 2012-08-24 RU RU2014111465/15A patent/RU2580294C2/ru active
- 2012-08-24 PT PT127751238T patent/PT2749291T/pt unknown
-
2014
- 2014-02-14 CL CL2014000386A patent/CL2014000386A1/es unknown
- 2014-02-19 ZA ZA2014/01271A patent/ZA201401271B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhu et al. | Single-walled carbon nanotubes as candidate recombinant subunit vaccine carrier for immunization of grass carp against grass carp reovirus | |
| JP2012513479A5 (enExample) | ||
| ES2488941T3 (es) | Vectores y constructos de liberación de antígenos de virus de la gripe | |
| Wang et al. | The protective immunity against grass carp reovirus in grass carp induced by a DNA vaccination using single-walled carbon nanotubes as delivery vehicles | |
| Xu et al. | Superior protection conferred by inactivated whole virus vaccine over subunit and DNA vaccines against salmonid alphavirus infection in Atlantic salmon (Salmo salar L.) | |
| JP2012503011A5 (ja) | 慢性ｃ型肝炎ウイルス感染症のための酵母系免疫治療組成物 | |
| JP2009537143A5 (enExample) | ||
| JP2017523225A5 (enExample) | ||
| Kim et al. | Comparison of the efficacy of Poly (I: C) immunization with live vaccine and formalin-killed vaccine against viral hemorrhagic septicemia virus (VHSV) in olive flounder (Paralichthys olivaceus) | |
| JP2016504315A5 (enExample) | ||
| Myoung | Two years of COVID-19 pandemic: where are we now? | |
| Louz et al. | Animal models in virus research: their utility and limitations | |
| JP2010506926A5 (enExample) | ||
| JP2014524450A5 (enExample) | ||
| JP2016528176A5 (enExample) | ||
| JP5132780B2 (ja) | 水産用サブユニットワクチン | |
| US11304989B2 (en) | Peptides for use in the treatment of viral infections | |
| Gorgoglione et al. | Viral and bacterial septicaemic infections modulate the expression of PACAP splicing variants and VIP/PACAP receptors in brown trout immune organs | |
| Kim et al. | Protection of olive flounder, Paralichthys olivaceus, against viral hemorrhagic septicemia virus (VHSV) by immunization with NV gene-knockout recombinant VHSV | |
| RU2014111465A (ru) | Применение расар в качестве молекулярного адъюванта для вакцин | |
| JP2019534242A5 (enExample) | ||
| US9872895B2 (en) | TLR5 ligands, therapeutic methods, and compositions related thereto | |
| JP2020500837A5 (enExample) | ||
| Martinez-Alonso et al. | Immune responses elicited in rainbow trout through the administration of infectious pancreatic necrosis virus-like particles | |
| Farhana et al. | Sars-CoV-2leader-RNA-primed Transcription and RNA-Splicing prevention, control and Treatment |